Effect of Black Raspberry Phytochemicals on Oral Microbiome in Current Smokers and Non-smokers
NCT02439255 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 148
Last updated 2022-10-05
Summary
This randomized clinical trial studies the effects of black raspberry compounds (phytochemicals) on the bacteria in the mouth (oral microbiome) of current smokers and non-smokers. The oral microbiome protects the body from pathogenic bacteria. Smoking alters the oral microbiome and may increase the susceptibility to cancer by modulating normal host-bacteria interactions. Black raspberry phytochemicals may protect the oral microbiome of smokers and may lower their risk of developing oral cancer.
Conditions
- Healthy Subject
- Tobacco Use Disorder
Interventions
- OTHER
-
Laboratory Biomarker Analysis
Correlative studies
- DIETARY_SUPPLEMENT
-
Phytochemical
Given black raspberry (BRB) nectar per oral (PO)
- OTHER
-
Placebo
Given PO
- OTHER
-
Screening Questionnaire Administration
Ancillary studies
Sponsors & Collaborators
-
National Cancer Institute (NCI)
collaborator NIH -
Ohio State University Comprehensive Cancer Center
lead OTHER
Principal Investigators
-
Purnima Kumar, MD · Ohio State University Comprehensive Cancer Center
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 50 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2015-12-04
- Primary Completion
- 2018-06-30
- Completion
- 2022-04-30
Countries
- United States
Study Locations
More Related Trials
-
The Oral Microbiome in OSCC
NCT04925700 ·Status: COMPLETED ·Phase: NA
-
The Oral Microbiome and Upper Aerodigestive Squamous Cell Cancer
NCT03304132 ·Status: COMPLETED
-
Double-blind-randomized,Placebo Controlled Trial for Chemotherapy-associated Oral Mucositis Using Doxycycline Hyclate
NCT01087476 ·Status: UNKNOWN ·Phase: PHASE2
-
Oral Microbioma and Oral Malignant Disease
NCT05766150 ·Status: UNKNOWN
-
CD2 Lozenges in Preventing Acute Oral Mucositis in Patients With Head and Neck Cancer Receiving Radiotherapy and Chemotherapy
NCT01545687 ·Status: WITHDRAWN ·Phase: PHASE3
-
Oral Care Protocol for the Management of Chemotherapy and Radiation Therapy-Induced Oral Mucositis
NCT02608879 ·Status: COMPLETED ·Phase: NA
-
Broccoli Sprout Extracts in Healthy Volunteers: A Pilot Study of Nrf2 Pathway Modulation in Oral Mucosa
NCT02023931 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Effect of N-Acetyl Cysteine (NAC) on the Oral Microbiome
NCT03982537 ·Status: WITHDRAWN ·Phase: PHASE2
-
A Phase III Study of Efficacy of Lactobacillus CD2 Lozenges in Preventing High-Dose Chemotherapy Induced Oral Mucositis in Patients Undergoing Myeloablative Hematopoietic Stem Cell Transplantation
NCT01797952 ·Status: WITHDRAWN ·Phase: PHASE3
-
Herbal Mouthrinse for Oral Mucositis Study
NCT01898091 ·Status: COMPLETED ·Phase: PHASE2
-
Behavior Change on Oral Cancer Patients After a Localized Behavior Change Model Intervention
NCT01351532 ·Status: COMPLETED ·Phase: NA
-
Oral Health and Oral Health-Related Quality of Life in Early Stage Breast Cancer Survivors
NCT01272570 ·Status: COMPLETED
-
A Randomized Study to Establish the Efficacy of Oral Ice Exposure During Oxaliplatin Infusion in Preventing Oral Cold Sensitivity
NCT03427021 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
d-Limonene +Radiation +PlatinumBasedChemo for Xerostomia Prevention in LocallyAdvanced HNSCC
NCT04392622 ·Status: RECRUITING ·Phase: PHASE1
-
Efficacy of Orosol® in the Treatment of Chemo- and Radiation-induced Mucositis.
NCT05161091 ·Status: RECRUITING ·Phase: NA
-
Evaluation of ONCOXIN® in Oral Mucositis, Appetite and Body Mass in Cancer Patients.
NCT03577535 ·Status: COMPLETED ·Phase: PHASE2
-
A Pilot Study of Efficacy of Lactobacillus CD2 Lozenges in Preventing High-dose Chemotherapy Induced Oral Mucositis in Patients Undergoing Hematopoietic Stem Cell Transplantation
NCT01480011 ·Status: COMPLETED ·Phase: PHASE2
-
Randomised Study of Mucositis Prevention After Radiochemotherapy Treatment for Head and Neck Cancer
NCT01149642 ·Status: COMPLETED ·Phase: NA
-
Photographic Evidence of Oral Precancerous Lesions in Current Tobacco and Areca Nut Users Improves Their Quit Rates
NCT05215860 ·Status: COMPLETED ·Phase: NA
-
Tobacco and Alcohol Influence on Oncogenic Drivers and Somatic Evolution in the Oral Mucosa
NCT06094829 ·Status: COMPLETED
-
Commensal Oral Microbiota in Head and Neck Cancer
NCT03843554 ·Status: TERMINATED ·Phase: NA
-
Innovative Approach to Triage Oral Precancer
NCT03202810 ·Status: UNKNOWN
-
Benefits of Immunonutrition in Patients With Head and Neck Cancer Receiving Chemoradiation
NCT05101889 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Lactobacillus Brevis CD2 in Prevention of Radio-chemotherapy Induced Oral Mucositis in Head and Neck Cancer
NCT01707641 ·Status: UNKNOWN ·Phase: PHASE4
-
Compound Staphylococcal Lysostaphin Vs. Chlorhexidine Mouthrinse for Oral Mucositis in Patients Undergoing Allo-HSCT
NCT06791746 ·Status: COMPLETED ·Phase: PHASE3